GSTM1, GSTT1 and CYP1A1 polymorphisms and risk of oral cancer: A case-control study in Jakarta, Indonesia

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 1, 2009, Pages 21-26

  Amtha, Rahmi ^a,c   Ching, Cheong Sok ^b   Zain, Rosnah ^c   Razak, Ishak Abdul ^c   Basuki, Bastaman ^d   Roeslan, Boedi Oetomo ^c   Gautama, Walta ^d   Purwanto, Denny ^d  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Cancer Research Initiatives Foundation (CARIF) Subang Jaya   (Malaysia)

^c TRISAKTI UNIVERSITY   (Indonesia)

^d UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Indonesia; Jakarta; Metabolizing enzyme polymorphisms; Oral cancer risk

Indexed keywords

EID: 67650882694     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Buch SC, Notani PN, Bhisey RA (2002). Polymorphism at GSTM1, GSTM3 and GSTT gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis, 23, 803.
2. Cha In-Ho, Park JY, Chung WY, et al (2007). Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J, 48, 233-9.
3. Deakin M, Elder J, Hendrickse C, et al (1996). Glutathione Stransferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis, 17, 881-4
4. Geisler SA, Oshan AF (2001). GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A mini-HuGE review. Am J Epidemiol, 154, 95-105.
5. Hahn M, Hagedorn G, Kuhlisch E, Schackert HK, Eckelt U (2002). Genetic polymorphism for drug metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol, 38, 486-90.
6. Hashibe M, Brennan P, Stange RC, et al (2003). Meta and pooled analysis of GSTM1, GSTT1, GSTP1 and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomark Prevent, 12, 1509-17.
7. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. (1991). PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res, 10, 4797.
8. Hayes JD, Pulford DJ (1995). The glutathione s-transferas supergene family: regulation of GST and the contribution of isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
9. Hung HC, Chuang J, Chien YC, et al (1997). Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev, 6, 901-5.
10. Jacob BJ, Straif K, Thomas G, et al (2004). Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol, 40, 697-704.
11. Katoh T, Kaneko S, Kohshi K, et al (1999). Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer, 83, 606-9.
12. Kietthubthew S, Sriplung H, Au WW (2001). Genetic and environmental interactions on oral cancer in Southern Thailand. Environ Molec Mutagen, 37, 111-6.
13. Kihara M, Kihara M, Kubota A, Furukawa M, Kimura H (1997). GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett, 11, 257-62.
14. Lazarus P, Park PY (2000). Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol, 36, 421-31.
15. Mannervik B, Alin P, Guthenberg C, et al (1985). Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA, 82, 7202-6.
16. Mannervik B, Awatshi YC, Board PG, Hayes JD, Di Ilio C (1992). Nomenclature for human glutathione S-transferases. Biochem J, 282, 305-8.
17. Marques CFS, Koifman S, Koifman RJ, et al (2006). Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol, 42, 632-7.
18. Meyer DJ, Coles B, Pemble SE, et al (1991). Theta new classes of glutathione S-transferases purified from rat and man. Biochem J, 274, 409-14.
19. Morita S, Yano M, Tsujinaka T, et al (1999). Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head and neck squamous cell carcinoma. Int J Cancer, 80, 685-8.
20. Nair UJ, Nair J, Mathew B, Bartsch H (1999). Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis, 20, 743-54.
21. Nasca PC (2001). Biomarkers and epidemiology studies of cancer. In Philip C. Nasca and Harris Pastides. (eds). Fundamentals of Cancer Epidemiology. Maryland Aspen. 1-21.
22. Olshan AF, Weissler MC, Watson MA, Bell DA. (2000). GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev, 9, 185-91.
23. Oude Ophuis MB, van Lieshout EM, et al (1998). Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer, 82, 936-94.
24. Park JY, Muscat JE, Ren Q, et al (1997). CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomark Prev, 6, 791-7.
25. Park JY, Muscat JE, Kaur T, et al (2000). Comparison of GSTM polymorphisms and risk of oral cancer between African-American and Caucasians. Pharmacogenetics, 10, 123-31.
26. Pemble S, Schroeder KR, Spencer SR, et al (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J, 15, 271-6.
27. Rebbeck TR (1997). Molecular epidemiology of human gluthation S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev, 6, 733-43.
28. Sato M, Sato T, Izumo T, Amagasa T (1999). Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis, 20, 1927-31.
29. Sharma A, Mishra A, Das BC, Sardana S, Sharma JK (2006). Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Neoplasma, 53, 309-15.
30. Stewart BW, Kleihues P (2003a) Head and neck cancer. In Bernard W Stewart and Paul Kleihues (eds).'World Cancer Report'. Lyon France, IARC Press, p.232-5.
31. Stewart BW, Kleihues P. (2003b) The cause of cancer. In Bernard W Stewart and Paul Kleihues (eds).'World Cancer Report'. Lyon France, IARC Press, p.22-31.
32. Sreelekha TT, Ramadas K, Pandey M, et al (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol, 37, 593-8.
33. Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T (1999). Polymorphisms of the CYP 1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol, 35, 191-6.
34. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA (2004). Environmental and chemical carcinogenesis. Semin Cancer Biol, 14, 473-86.
35. Worrall S, Corrigan M, High A, et al (1998). Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics, 8, 433-9.
36. Yang YH, Lien YC, Ho PS, et al (2005) The effects of chewing areca /betel quid with or without cigarette smoking on oral submucous fibrosis and oral mucosa lesions. Oral Dis, 11, 88-94.
37. Ye Z, Song H, Guo Y (2004). Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: meta-analysis. J Med Genet, 41, 360-5.
38. Zheng T, Boyle P, Walter WC, et al (1993). A case-control study of oral cancer in Beijing, People's Republic of China. Association with nutrient intakes, foods and food groups. Oral Oncol Eur J Cancer, 29B, 45-55.
39. Zheng W (2001). Epidemiological studies of genetics factors for cancer. In Philip C Nasca and Harris Pastides. (eds). 'Fundamentals of Cancer Epidemiology'. Maryland, Aspen, p.103-12.
40. Znaor A, Brennan P, Gajalakshmi V, et al (2003). Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer, 105, 681-6.